Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pneumonia.

S K Kabra1, T Singhal, R Lodha

  • 1Department of Pediatrics, All India Institute of Medical Sciences, New Delhi. skkabra@hotmail.com

Indian Journal of Pediatrics
|May 1, 2002
PubMed
Summary
This summary is machine-generated.

Pneumonia is a major cause of death in young children, often bacterial. Treatment choice depends on severity and risk factors, with amoxicillin a common option for uncomplicated community-acquired pneumonia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Profile of Cystic Fibrosis in India: A Multi-Centric Prospective Study.

Journal of paediatrics and child health·2026
Same author

Clinical Signs of Circulatory Impairment/Shock in Children: A Prospective Observational Study.

Indian journal of pediatrics·2026
Same author

Factors associated with pulmonary TB in malnourished children admitted to rehabilitation centres.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2026
Same author

Profile of cystic fibrosis transmembrane conductance regulator (CFTR) gene variants across India and their variability in different geographic regions.

Gene·2025
Same author

Genotype-Phenotype Correlation in Children With Cystic Fibrosis From India: A Multicentric Study.

Clinical genetics·2025
Same author

Vitamin C Versus Placebo in Pediatric Septic Shock (VITACiPS) - A Randomised Controlled Trial.

Journal of intensive care medicine·2025
Same journal

Beyond Proteinuria: Does Growth Matter in Childhood Nephrotic Syndrome?

Indian journal of pediatrics·2026
Same journal

Impulse Oscillometry for Pulmonary Function Evaluation in Children with Neuromuscular Disease: A Comparative Study with Spirometry - Correspondence.

Indian journal of pediatrics·2026
Same journal

Impact of Enzyme Replacement Therapy on Patients with Late Onset Pompe Disease - Real World Data from a Developing Country.

Indian journal of pediatrics·2026
Same journal

Reciprocal Interaction Loss During Screen-Assisted Feeding: The Dominant Language Risk Component in Early Childhood.

Indian journal of pediatrics·2026
Same journal

Bilateral Parotid Enlargement as an Initial Manifestation of Pediatric Acute Lymphoblastic Leukemia.

Indian journal of pediatrics·2026
Same journal

Hemorrhagic Cardiac Tamponade Due to MRSA Sepsis in a Child with Relapsed Acute Lymphoblastic Leukemia: Authors' Reply.

Indian journal of pediatrics·2026
See all related articles

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pharmacology

Background:

  • Pneumonia is a leading cause of mortality and morbidity in children under five.
  • Bacterial agents commonly cause pneumonia, diagnosed via clinical features.
  • Disease severity is classified by symptoms like tachypnea, chest indrawing, and feeding difficulty.

Purpose of the Study:

  • To outline antibiotic selection criteria for pediatric pneumonia.
  • To differentiate treatment strategies based on risk factors and disease severity.

Main Methods:

  • Classification of pneumonia into community-acquired (with/without risk factors) and severe/non-severe categories.
  • Identification of clinical features for diagnosing pneumonia and its severity.
  • Review of factors influencing antibiotic choice, including pathogens, resistance, and patient status.

Related Experiment Videos

Main Results:

  • Amoxicillin is recommended for uncomplicated community-acquired pneumonia in children aged 2-60 months.
  • Alternative oral antibiotics include cephalosporins and cotrimoxazole.
  • Non-severe pneumonia with risk factors may be treated with cefuroxime or amoxicillin clavulinic acid for 7-14 days.

Conclusions:

  • Antibiotic selection for pediatric pneumonia requires careful consideration of etiological agents, disease severity, and patient-specific factors.
  • Tailored antibiotic regimens are crucial for effective management of pediatric pneumonia.